Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424403 | PMC |
http://dx.doi.org/10.1007/s00259-021-05553-3 | DOI Listing |
Nihon Ronen Igakkai Zasshi
January 2024
Department of Pathology, Tokyo Medical University Hachioji Medical Center.
Giant cell arteritis (GCA) is closely associated with polymyalgia rheumatica (PMR). We herein report an 82-year-old woman who developed GCA during PMR treatment. She initially presented with shoulder pain and was diagnosed with PMR based on elevated serum C-reactive protein (CRP) levels and bursitis detected in both shoulders on ultrasonography (US).
View Article and Find Full Text PDFMedicine (Baltimore)
September 2023
Izmir Katip Celebi University Izmir Atatürk Research and Training Hospital, Department of Radiology, Izmir, Turkey.
Polymyalgia Rheumatica (PMR) is an inflammatory disease which does not have specific diagnostic tests or pathological symptoms and is identified based on clinical characteristics. Among acute phase reactants (APR), the erythrocyte sedimentation rate (ESR) and C-Reactive Protein (CRP) are laboratory findings used in diagnosis and follow-up. In this study, it was aimed to determine the incidence of normal ESH and CRP in patients diagnosed with PMR and identify the distinguishing characteristics of these patients.
View Article and Find Full Text PDFFront Neurol
September 2023
Department of Neurology, Peking University People's Hospital, Beijing, China.
Giant cell arteritis (GCA) is a kind of systemic vasculitis affecting individuals over 50 years old and is often the cause of new-onset headaches in older adults. Patients with GCA sometimes have rheumatic polymyalgia (PMR). The diagnosis of GCA generally depends on clinical manifestation, elevated erythrocyte sedimentation rate (ESR) or C-reactive protein, and positive imaging findings commonly obtained by ultrasound or temporal artery biopsy.
View Article and Find Full Text PDFIntern Emerg Med
October 2023
Department of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Viale Mario Bracci, 53100, Siena, Italy.
To assess the rate of PMR who, during the follow-up, undergo a diagnostic shift as well as to assess which clinical, laboratory and US findings are associated to a diagnostic shift and predict the long-term evolution of PMR. All PMR followed-up for at least 12 months were included. According to the US procedures performed at diagnosis, patients were subdivided into four subgroups.
View Article and Find Full Text PDFRMD Open
November 2022
Inflammation and Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!